10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001651308-22-000209`
Period End Date	20220930
Filing Date	20221109
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	bgne-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 80 Cash Flow Statement 87 Stockholders Equity 47 Comprehensive Income 20

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.20B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$191.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.33B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.35B	shares	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$2.24B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$872.00M	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$483.11M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$189.17M	USD	Point-in-time
Inventories	`InventoryNet`	$290.91M	USD	Point-in-time
Inventories	`InventoryNet`	$242.63M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.77M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$270.17M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.75B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.61B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.06M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.19M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$681.91M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$587.61M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$117.43M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$110.34M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$46.68M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$40.85M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$140.55M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$163.05M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$921.64M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$976.85M	USD	Point-in-time
Total assets	`Assets`	$6.73B	USD	Point-in-time
Total assets	`Assets`	$8.54B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$262.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$252.07M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$558.05M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$410.25M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$144.98M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$187.41M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$22.66M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$21.39M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$21.93M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$24.34M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$120.80M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$115.72M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$441.27M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	3.14B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.72B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$427.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.41B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.48B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.29B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$208.06M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$202.11M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$220.29M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$149.90M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$43.04M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$36.90M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$14.17M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$15.25M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$204.25M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$269.56M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$45.17M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$54.23M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$659.53M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$803.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.07B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.40B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,349,640,180 and 1,334,804,281 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$135.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,349,640,180 and 1,334,804,281 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$133.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.19B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.45B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.95M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-161.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.08B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.64B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.66B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.13B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.54B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$6.73B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$206.44M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$962.30M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$387.63M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.04B	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$116.36M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$47.41M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$76.54M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$212.95M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$426.36M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.19B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$351.94M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.03B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$322.89M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$683.62M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$948.87M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$269.23M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$187.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$563.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$563.00K	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$825.99M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$2.36B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$1.83B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$668.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-438.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-462.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-867.00M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.32B	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$34.26M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$12.76M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-11.28M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-2.23M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-125.64M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-243.29M	USD	3 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$26.49M	USD	3 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$31.48M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.53B	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-551.24M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-851.78M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-433.08M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$5.04M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$6.32M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$28.41M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$15.35M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-438.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-867.14M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-557.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56B	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.41	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.16	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.36	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.72	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.36	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.16	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.41	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.72	USD	3 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.20B	shares	3 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.35B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.21B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.34B	shares	3 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.35B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.21B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.34B	shares	3 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.20B	shares	3 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-5.39	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-4.72	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-9.42	USD	3 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-15.14	USD	3 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-15.14	USD	3 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-5.39	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-4.72	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-9.42	USD	3 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.92M	shares	3 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	92.03M	shares	3 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	92.77M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	103.48M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	92.03M	shares	3 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	103.48M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	92.77M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.92M	shares	3 Qtrs

Cash Flow Statement 87 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-438.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-867.14M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-557.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56B	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$33.34M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$48.26M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$225.04M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$177.70M	USD	3 Qtrs
Unrealized losses (gains) on equity investments	`IncomeLossFromEquityMethodInvestments`	$-16.41M	USD	3 Qtrs
Unrealized losses (gains) on equity investments	`IncomeLossFromEquityMethodInvestments`	$17.17M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$20.00M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$53.50M	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-82.85M	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-70.39M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$2.47M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$380.00K	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$17.72M	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$7.76M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-284.72M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$69.17M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$61.69M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$75.63M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.32M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$92.49M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-12.38M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.20M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.63M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-44.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$124.90M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-112.82M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.41M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$167.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-790.88M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.18B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$147.96M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$204.08M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$2.06B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$14.73M	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.35B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.76B	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$95.00M	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$8.50M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$7.50M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.04B	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$531.55M	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$50.00M	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$16.84M	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$37.37M	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$143.46M	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$163.77M	USD	3 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$40.23M	USD	3 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$145.43M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$35.68M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$82.19M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$91.39M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$252.26M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-133.93M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.77M	USD	3 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-182.38M	USD	3 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-309.00K	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.20B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.20B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.20B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.38B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$191.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$328.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.88M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.06M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.19M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$25.01M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$15.21M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$23.40M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$19.86M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$47.31M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$41.90M	USD	3 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	-	USD	3 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	$45.00M	USD	3 Qtrs

Stockholders Equity 47 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.25B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.53B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.20B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.13B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.93B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.66B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.77B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.80B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time
Cost from issuance of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$152.00K	USD	1 Quarter
Proceeds from issuance of ordinary shares, net of cost	`StockIssuedDuringPeriodValueNewIssues`	$50.00M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$9.85M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$25.75M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.88M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$16.70M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$7.09M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$46.59M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.83M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$81.31M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$78.18M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$67.08M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.56M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$64.79M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-496.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-79.07M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-99.90M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$485.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-179.47M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$8.89M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.74M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-435.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-557.56M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-565.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-484.60M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$55.58M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-438.11M	USD	1 Quarter
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.25B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.53B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.20B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.13B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.93B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.66B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.77B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.80B	USD	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.35B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.33B	shares	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-438.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-867.14M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-557.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56B	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$664.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$6.53M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-80.33M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-168.41M	USD	3 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	3 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$111.00K	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-250.00K	USD	3 Qtrs
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-11.06M	USD	3 Qtrs
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-68.00K	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.25M	USD	1 Quarter
Unrealized holding loss, net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.14M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-636.63M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-437.63M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.74B	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-861.50M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.